Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.280
Filter
1.
Sci Rep ; 14(1): 15631, 2024 07 07.
Article in English | MEDLINE | ID: mdl-38972872

ABSTRACT

The use of lactose and cow milk protein (CMP) as potential allergens in pharmaceuticals and their ability to cause allergic reactions remains a significant concern in medicine. Lactose, a common pharmaceutical excipient due to its inert, inexpensive, and stable properties, is found in many prescription-only and over-the-counter medications. However, despite their widespread use, individuals with lactose intolerance (LI) or cow milk protein allergy (CMPA) may experience adverse reactions to these excipients. This study investigated the prevalence of lactose and other dairy-derived ingredients in pharmaceuticals marketed in Portugal. Using the Summary of Product Characteristics (SmPC) from the INFOMED database, various medications, including analgesics, antipyretics, non-steroidal anti-inflammatory drugs (NSAIDs), and antiasthmatics, were analyzed. Results showed a high prevalence of dairy-derived excipients, particularly in antiasthmatic drugs (62.6%) and NSAIDs (39%). Although CMP are not explicitly mentioned in SmPCs, the presence of lactose as an ingredient poses a risk of cross-contamination. The findings emphasize the need for healthcare professionals to be aware of potential allergens in medications and the importance of developing lactose-free alternatives to ensure the safety of patients with LI and CMPA. Further research is required to assess the safety and implications of lactose in medicines for these populations.


Subject(s)
Excipients , Lactose Intolerance , Lactose , Milk Hypersensitivity , Humans , Excipients/adverse effects , Excipients/chemistry , Milk Hypersensitivity/epidemiology , Animals , Lactose/adverse effects , Lactose/analysis , Lactose/chemistry , Cattle , Milk Proteins/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/analysis , Allergens/analysis , Portugal , Dairy Products/analysis , Dairy Products/adverse effects
2.
ACS Macro Lett ; 13(7): 874-881, 2024 Jul 16.
Article in English | MEDLINE | ID: mdl-38949618

ABSTRACT

The frequent mutations of influenza A virus (IAV) have led to an urgent need for the development of innovative antiviral drugs. Glycopolymers offer significant advantages in biomedical applications owing to their biocompatibility and structural diversity. However, the primary challenge lies in the design and synthesis of well-defined glycopolymers to precisely control their biological functionalities. In this study, functional glycopolymers with sulfated fucose and 6'-sialyllactose were successfully synthesized through ring-opening metathesis polymerization and a postmodification strategy. The optimized heteropolymer exhibited simultaneous targeting of hemagglutinin and neuraminidase on the surface of IAV, as evidenced by MU-NANA assay and hemagglutination inhibition data. Antiviral experiments demonstrated that the glycopolymer displayed broad and efficient inhibitory activity against wild-type and mutant strains of H1N1 and H3N2 subtypes in vitro, thereby establishing its potential as a dual-targeted inhibitor for combating IAV resistance.


Subject(s)
Antiviral Agents , Fucose , Influenza A Virus, H1N1 Subtype , Lactose , Antiviral Agents/pharmacology , Antiviral Agents/chemistry , Antiviral Agents/chemical synthesis , Lactose/analogs & derivatives , Lactose/chemistry , Lactose/pharmacology , Fucose/chemistry , Fucose/analogs & derivatives , Fucose/pharmacology , Influenza A Virus, H1N1 Subtype/drug effects , Influenza A Virus, H3N2 Subtype/drug effects , Drug Resistance, Viral/drug effects , Humans , Neuraminidase/antagonists & inhibitors , Neuraminidase/metabolism , Influenza A virus/drug effects , Madin Darby Canine Kidney Cells , Animals , Dogs , Polymers/pharmacology , Polymers/chemistry
3.
Int J Mol Sci ; 25(13)2024 Jun 25.
Article in English | MEDLINE | ID: mdl-39000066

ABSTRACT

Galectins are multifunctional effectors in cellular homeostasis and dysregulation. Oxidation of human galectin-1 (Gal-1) with its six sulfhydryls produces a disulfide-bridged oxidized form that lacks normal lectin activity yet gains new glycan-independent functionality. Nevertheless, the mechanistic details as to how Gal-1 oxidation occurs remain unclear. Here, we used 15N and 13C HSQC NMR spectroscopy to gain structural insight into the CuSO4-mediated path of Gal-1 oxidation and identified a minimum two-stage conversion process. During the first phase, disulfide bridges form slowly between C16-C88 and/or C42-C66 to produce a partially oxidized, conformationally flexible intermediate that retains the ability to bind lactose. Site-directed mutagenesis of C16 to S16 impedes the onset of this overall slow process. During the second phase, increased motional dynamics of the intermediate enable the relatively distant C2 and C130 residues to form the third and final disulfide bond, leading to an unfolded state and consequent dimer dissociation. This fully oxidized end state loses the ability to bind lactose, as shown by the hemagglutination assay. Consistent with this model, we observed that the Gal-1 C2S mutant maintains intermediate-state structural features with a free sulfhydryl group at C130. Incubation with dithiothreitol reduces all disulfide bonds and allows the lectin to revert to its native state. Thus, the sequential, non-random formation of three disulfide bridges in Gal-1 in an oxidative environment acts as a molecular switch for fundamental changes to its functionality. These data inspire detailed bioactivity analysis of the structurally defined oxidized intermediate in, e.g., acute and chronic inflammation.


Subject(s)
Cysteine , Galectin 1 , Oxidation-Reduction , Galectin 1/metabolism , Galectin 1/chemistry , Galectin 1/genetics , Humans , Cysteine/metabolism , Cysteine/chemistry , Disulfides/metabolism , Disulfides/chemistry , Protein Folding , Protein Unfolding , Models, Molecular , Lactose/metabolism , Lactose/chemistry , Mutagenesis, Site-Directed
4.
AAPS PharmSciTech ; 25(6): 138, 2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38890193

ABSTRACT

Unexpected cross-contamination by foreign components during the manufacturing and quality control of pharmaceutical products poses a serious threat to the stable supply of drugs and the safety of customers. In Japan, in 2020, a mix-up containing a sleeping drug went undetected by liquid chromatography during the final quality test because the test focused only on the main active pharmaceutical ingredient (API) and known impurities. In this study, we assessed the ability of a powder rheometer to analyze powder characteristics in detail to determine whether it can detect the influence of foreign APIs on powder flow. Aspirin, which was used as the host API, was combined with the guest APIs (acetaminophen from two manufacturers and albumin tannate) and subsequently subjected to shear and stability tests. The influence of known lubricants (magnesium stearate and leucine) on powder flow was also evaluated for standardized comparison. Using microscopic morphological analysis, the surface of the powder was observed to confirm physical interactions between the host and guest APIs. In most cases, the guest APIs were statistically detected due to characteristics such as their powder diameter, pre-milling, and cohesion properties. Furthermore, we evaluated the flowability of a formulation incorporating guest APIs for direct compression method along with additives such as microcrystalline cellulose, potato starch, and lactose. Even in the presence of several additives, the influence of the added guest APIs was successfully detected. In conclusion, powder rheometry is a promising method for ensuring stable product quality and reducing the risk of unforeseen cross-contamination by foreign APIs.


Subject(s)
Drug Contamination , Powders , Rheology , Powders/chemistry , Rheology/methods , Drug Contamination/prevention & control , Excipients/chemistry , Acetaminophen/chemistry , Cellulose/chemistry , Pharmaceutical Preparations/chemistry , Quality Control , Aspirin/chemistry , Chemistry, Pharmaceutical/methods , Lactose/chemistry , Drug Compounding/methods , Lubricants/chemistry , Bulk Drugs
5.
Pharm Res ; 41(6): 1201-1216, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38834905

ABSTRACT

BACKGROUND: Some glucoside drugs can be transported via intestinal glucose transporters (IGTs), and the presence of carbohydrate excipients in pharmaceutical formulations may influence the absorption of them. This study, using gastrodin as probe drug, aimed to explore the effects of fructose, lactose, and arabic gum on intestinal drug absorption mediated by the glucose transport pathway. METHODS: The influence of fructose, lactose, and arabic gum on gastrodin absorption was assessed via pharmacokinetic experiments and single-pass intestinal perfusion. The expression of sodium-dependent glucose transporter 1 (SGLT1) and sodium-independent glucose transporter 2 (GLUT2) was quantified via RT‒qPCR and western blotting. Alterations in rat intestinal permeability were evaluated through H&E staining, RT‒qPCR, and immunohistochemistry. RESULTS: Fructose reduced the area under the curve (AUC) and peak concentration (Cmax) of gastrodin by 42.7% and 63.71%, respectively (P < 0.05), and decreased the effective permeability coefficient (Peff) in the duodenum and jejunum by 58.1% and 49.2%, respectively (P < 0.05). SGLT1 and GLUT2 expression and intestinal permeability remained unchanged. Lactose enhanced the AUC and Cmax of gastrodin by 31.5% and 65.8%, respectively (P < 0.05), and increased the Peff in the duodenum and jejunum by 33.7% and 26.1%, respectively (P < 0.05). SGLT1 and GLUT2 levels did not significantly differ, intestinal permeability increased. Arabic gum had no notable effect on pharmacokinetic parameters, SGLT1 or GLUT2 expression, or intestinal permeability. CONCLUSION: Fructose, lactose, and arabic gum differentially affect intestinal drug absorption through the glucose transport pathway. Fructose competitively inhibited drug absorption, while lactose may enhance absorption by increasing intestinal permeability. Arabic gum had no significant influence.


Subject(s)
Benzyl Alcohols , Excipients , Fructose , Glucose Transporter Type 2 , Glucose , Glucosides , Gum Arabic , Intestinal Absorption , Lactose , Rats, Sprague-Dawley , Sodium-Glucose Transporter 1 , Animals , Intestinal Absorption/drug effects , Glucosides/pharmacology , Glucosides/administration & dosage , Glucosides/pharmacokinetics , Sodium-Glucose Transporter 1/metabolism , Sodium-Glucose Transporter 1/genetics , Male , Glucose Transporter Type 2/metabolism , Glucose Transporter Type 2/genetics , Rats , Excipients/chemistry , Excipients/pharmacology , Glucose/metabolism , Lactose/chemistry , Benzyl Alcohols/pharmacology , Benzyl Alcohols/pharmacokinetics , Intestinal Mucosa/metabolism , Intestinal Mucosa/drug effects , Biological Transport/drug effects , Permeability/drug effects
6.
Int J Pharm ; 660: 124354, 2024 Jul 20.
Article in English | MEDLINE | ID: mdl-38897486

ABSTRACT

During recent years there have been shortages of certain drugs due to problems in raw material supply. These are often related to active ingredients but could also affect excipients. Lactose is one of the most used excipients in tableting and comes in two anomeric and several solid-state forms. The aim of this study was to utilize lactose from a dairy side-stream and compare it against a commercial reference in direct compression. This would be a sustainable option and would secure domestic availability during crises. Two types of lactose, spray-dried and freeze-dried, were evaluated. Lactose was mixed with microcrystalline cellulose in different ratios together with lubricant and glidant, and flowability and tabletability of the formulations was characterized. The fully amorphous and small particle-sized spray-dried lactose flowed inadequately but exhibited good tabletability. The larger particle-sized, freeze-dried lactose exhibited sufficient flow and better tabletability than the commercial reference. However, disintegration and drug release were slower when using the investigational lactose formulations. This was most likely due to remaining milk proteins, especially caseins, in the lactose. Overall, the investigational lactose provides promise for the use of such a side-stream product during crisis situations but enhancing their properties and/or purity would be needed.


Subject(s)
Cellulose , Drug Compounding , Drug Liberation , Excipients , Freeze Drying , Lactose , Tablets , Lactose/chemistry , Excipients/chemistry , Cellulose/chemistry , Drug Compounding/methods , Proof of Concept Study , Particle Size , Spray Drying , Dairying , Chemistry, Pharmaceutical/methods
7.
Int J Pharm ; 660: 124366, 2024 Jul 20.
Article in English | MEDLINE | ID: mdl-38901541

ABSTRACT

This research investigates the modeling of the pharmaceutical roller compaction process, focusing on the application of the Johanson model and the impact of varying roll speeds from 1 to 15 RPM on predictive accuracy of ribbon solid fraction. The classical Johanson's model was integrated with a dwell time parameter leading to an expression of a floating correction factor as a function of roll speed. Through systematic analysis of the effect of different roll speeds on the solid fraction of ribbons composed of microcrystalline cellulose, lactose, and their blends, corrective adjustment to the Johanson model was found to depend on both roll speed and formulation composition. Interestingly, the correction factor demonstrated excellent correlation with the blend's mechanical properties, namely yield stress (Py) and elastic modulus (E0), representative of the deformability of the powder. Validated by a multicomponent drug formulation with ±0.4-1.3 % differences, the findings underscore the utility of this modified mechanistic approach for precise prediction of ribbon solid fraction when Py or E0 is known for a given blend. Hence, this work advances the field by offering early insights for more accurate and controllable roller compaction operations during late-stage pharmaceutical manufacturing.


Subject(s)
Cellulose , Drug Compounding , Excipients , Lactose , Powders , Cellulose/chemistry , Lactose/chemistry , Drug Compounding/methods , Excipients/chemistry , Powders/chemistry , Chemistry, Pharmaceutical/methods , Elastic Modulus
8.
Biomacromolecules ; 25(7): 4428-4439, 2024 Jul 08.
Article in English | MEDLINE | ID: mdl-38917058

ABSTRACT

Carbonyl cross-linkers are used to modify textiles and form resins, and are produced annually in megatonne volumes. Due to their toxicity toward the environment and human health, however, less harmful biobased alternatives are needed. This study introduces carbonyl groups to lactose and galactose using galactose oxidase from Fusarium graminearum (FgrGalOx) and pyranose dehydrogenase from Agaricus bisporus (AbPDH1) to produce four cross-linkers. Differential scanning calorimetry was used to compare cross-linker reactivity, most notably resulting in a 34 °C decrease in reaction peak temperature (72 °C) for FgrGalOx-oxidized galactose compared to unmodified galactose. Attenuated total reflectance Fourier-transform infrared (ATR-FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), and proton nuclear magnetic resonance (1H NMR) spectroscopy were used to verify imine formation and amine and aldehyde depletion. Cross-linkers were shown to form gels when mixed with polyallylamine, with FgrGalOx-oxidized lactose forming gels more effectively than all other cross-linkers, including glutaraldehyde. Further development of carbohydrate cross-linker technologies could lead to their adoption in various applications, including in adhesives, resins, and textiles.


Subject(s)
Cross-Linking Reagents , Oxidation-Reduction , Polyamines , Cross-Linking Reagents/chemistry , Polyamines/chemistry , Galactose Oxidase/chemistry , Galactose Oxidase/metabolism , Galactose/chemistry , Lactose/chemistry , Agaricus/chemistry , Carbohydrates/chemistry
9.
Int J Biol Macromol ; 273(Pt 1): 132992, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38857718

ABSTRACT

ß-D-galactosidase is a hydrolase enzyme capable of hydrolyzing lactose in milk-based foods. Its free form can be inactivated in solution during the production of low-dosage lactose foods. Then, it is important to study strategies for avoiding the free enzyme inactivation with the aim of circumventing this problem. The stabilization of ß-D-galactosidase in aqueous solution after interactions with chitosan/eucalyptus sawdust composite membrane proved to be a potential strategy when optimized by central composite rotatable (CCR) design. In this case, the best experimental conditions for ß-D-galactosidase partitioning and stability in an aqueous medium containing the chitosan-based composite membrane reinforced with eucalyptus sawdust were i) enzyme/buffer solution ratio of 0.0057, ii) pH 5.6, iii) membrane mass of 50 mg, and iv) temperature lower than 37 °C. Significance was found for the linear enzyme/buffer solution ratio, linear temperature, and quadratic pH (p < 0.05) in the interval between 0 and 60 min of study. In the interval between 60 and 120 min, there was significance (p < 0.12) for linear temperature, the temperature-enzyme/buffer solution ratio interaction and the interaction between linear pH and linear enzyme/buffer solution ratio. The Pareto charts and response surfaces clearly showed all the effects of the experimental variables on the stabilization of ß-D-galactosidase in solution after interactions with the chitosan composite membrane. In this case, industrial food reactors covered with chitosan/eucalyptus sawdust composite membrane could be a strategy for the hydrolysis of lactose during milk-producing processes.


Subject(s)
Chitosan , Enzyme Stability , beta-Galactosidase , Chitosan/chemistry , beta-Galactosidase/chemistry , beta-Galactosidase/metabolism , Hydrogen-Ion Concentration , Membranes, Artificial , Solutions , Temperature , Lactose/chemistry
10.
AAPS PharmSciTech ; 25(6): 147, 2024 Jun 27.
Article in English | MEDLINE | ID: mdl-38937406

ABSTRACT

Only few excipients are known to be suitable as pelletization aids. In this study, the potential use of croscarmellose sodium (CCS) as pelletization aid was investigated. Furthermore, the impact of cations on extrusion-spheronization (ES) of CCS was studied and different grades of CCS were tested. The influence of different cations on the swelling of CCS was investigated by laser diffraction. Mixtures of CCS with lactose monohydrate as filler with or without the inclusion of different cations were produced. The mixtures were investigated by mixer torque rheometry and consequently extruded and spheronized. Resulting pellets were analyzed by dynamic image analysis. In addition, mixtures of different CCS grades with dibasic calcium phosphate anhydrous (DP) and a mixture with praziquantel (PZQ) as filler were investigated. Calcium and magnesium cations caused a decrease of the swelling of CCS and influenced the use of CCS as pelletization aid since they needed to be included for successful ES. Aluminum, however, led to an aggregation of the CCS particles and to failure of extrusion. The inclusion of cations decreased the uptake of water by the mixtures which also reduced the liquid-to-solid-ratio (L/S) for successful ES. This was shown to be dependent on the amount of divalent cations in the mixture. With DP or PZQ as filler, no addition of cations was necessary for a successful production of pellets, however the optimal L/S for ES was dependent on the CCS grade used. In conclusion, CCS can be used as a pelletization aid.


Subject(s)
Excipients , Particle Size , Excipients/chemistry , Drug Compounding/methods , Calcium Phosphates/chemistry , Lactose/chemistry , Chemistry, Pharmaceutical/methods , Cations/chemistry , Praziquantel/chemistry , Magnesium/chemistry
11.
Int J Pharm ; 660: 124315, 2024 Jul 20.
Article in English | MEDLINE | ID: mdl-38852747

ABSTRACT

The compendial USP〈701〉 disintegration test method offers a crucial pass/fail assessment for immediate release tablet disintegration. However, its single end-point approach provides limited insight into underlying mechanisms. This study introduces a novel calorimetric approach, aimed at providing comprehensive process profiles beyond binary outcomes. We developed a novel disintegration reaction calorimeter to monitor the heat release throughout the disintegration process and successfully obtained enthalpy change profiles of placebo tablets with various porosities. The formulation comprised microcrystalline cellulose (MCC), anhydrous lactose, croscarmellose sodium (CCS), and magnesium stearate (MgSt). An abrupt temperature rise was observed after introducing the disintegration medium to tablets, and the relationship between the heat rise time and the tablet's porosity was investigated. The calorimeter's sensitivity was sufficient to discern distinct heat changes among individual tablets, and the analysis revealed a direct correlation between the two. Higher porosity corresponded to shorter heat rise time, indicating faster disintegration rates. Additionally, the analysis identified a concurrent endothermic process alongside the anticipated exothermic phenomenon, potentially associated with the dissolution of anhydrous lactose. Since lactose is the only soluble excipient within the blend composition, the endothermic process can be attributed to the absorption of heat as lactose molecules dissolve in water. The findings from this study underscore the potential of utilising calorimetric methods to quantify the wettability of complex compounds and, ultimately, optimise tablet formulations.


Subject(s)
Calorimetry , Cellulose , Excipients , Hot Temperature , Lactose , Stearic Acids , Tablets , Lactose/chemistry , Cellulose/chemistry , Excipients/chemistry , Porosity , Stearic Acids/chemistry , Calorimetry/methods , Solubility , Carboxymethylcellulose Sodium/chemistry , Chemistry, Pharmaceutical/methods , Drug Liberation , Drug Compounding/methods
12.
Int J Pharm ; 657: 124190, 2024 May 25.
Article in English | MEDLINE | ID: mdl-38701910

ABSTRACT

Lubricants are essential for most tablet formulations as they assist powder flow, prevent adhesion to tableting tools and facilitate tablet ejection. Magnesium stearate (MgSt) is an effective lubricant but may compromise tablet strength and disintegratability. In the design of orodispersible tablets, tablet strength and disintegratability are critical attributes of the dosage form. Hence, this study aimed to conduct an in-depth comparative study of MgSt with alternative lubricants, namely sodium lauryl sulphate (SLS), stearic acid (SA) and hydrogenated castor oil (HCO), for their effects on the tableting process as well as tablet properties. Powder blends were prepared with lactose, sodium starch glycolate or crospovidone as the disintegrant, and a lubricant at different concentrations. Angle of repose was determined for the mixtures. Comparative evaluation was carried out based on the ejection force, tensile strength, liquid penetration and disintegratability of the tablets produced. As the lubricant concentration increased, powder flow and tablet ejection improved. The lubrication efficiency generally decreased as follows: MgSt > HCO > SA > SLS. Despite its superior lubrication efficacy, MgSt is the only lubricant of four evaluated that reduced tablet tensile strength. Tablet disintegration time was strongly determined by tensile strength and liquid penetration, which were in turn affected by the lubricant type and concentration. All the above factors should be taken into consideration when deciding the type and concentration of lubricant for an orodispersible tablet formulation.


Subject(s)
Excipients , Lubricants , Stearic Acids , Tablets , Tensile Strength , Lubricants/chemistry , Stearic Acids/chemistry , Excipients/chemistry , Drug Compounding/methods , Powders/chemistry , Sodium Dodecyl Sulfate/chemistry , Castor Oil/chemistry , Povidone/chemistry , Starch/chemistry , Starch/analogs & derivatives , Lactose/chemistry , Administration, Oral , Solubility , Chemistry, Pharmaceutical/methods
13.
Food Res Int ; 183: 114175, 2024 May.
Article in English | MEDLINE | ID: mdl-38760120

ABSTRACT

Lactose hydrolysed concentrated milk was prepared using ß-galactosidase enzyme (4.76U/mL) with a reaction period of 12 h at 4 °C. Addition of polysaccharides (5 % maltodextrin/ß-cyclodextrin) to concentrated milk either before or after lactose hydrolysis did not result in significant differences (p > 0.05) in degree of hydrolysis (% DH) of lactose and residual lactose content (%). Three different inlet temperatures (165 °C, 175 °C and 185 °C) were used for the preparation of powders which were later characterised based on physico-chemical and maillard browning characteristics. Moisture content, solubility and available lysine content of the powders decreased significantly, whereas, browning parameters i.e., browning index, 5-hydroxymethylfurfural, furosine content increased significantly (p < 0.05) with an increase in inlet air temperature. The powder was finally prepared with 5 % polysaccharide and an inlet air temperature of 185 °C which reduced maillard browning. Protein-polysaccharide interactions were identified using Fourier Transform infrared spectroscopy, fluorescence spectroscopy and determination of free amino groups in the powder samples. Maltodextrin and ß-cyclodextrin containing powder samples exhibited lower free amino groups and higher degree of graft value as compared to control sample which indicated protein-polysaccharide interactions. Results obtained from Fourier Transform infrared spectroscopy also confirmed strong protein-polysaccharide interactions, moreover a significant decrease in fluorescence intensity was also observed in the powder samples. These interactions between the proteins and polysaccharides reduced the maillard browning in powders.


Subject(s)
Furaldehyde , Lactose , Maillard Reaction , Milk , Polysaccharides , Powders , Lactose/chemistry , Polysaccharides/chemistry , Milk/chemistry , Animals , Spectroscopy, Fourier Transform Infrared , Furaldehyde/analogs & derivatives , Furaldehyde/chemistry , beta-Galactosidase/metabolism , beta-Cyclodextrins/chemistry , Hydrolysis , Spray Drying , Temperature , Lysine/chemistry , Lysine/analogs & derivatives , Solubility , Spectrometry, Fluorescence , Milk Proteins/chemistry , Food Handling/methods
14.
Int J Pharm ; 659: 124290, 2024 Jun 25.
Article in English | MEDLINE | ID: mdl-38821435

ABSTRACT

The influence of hydroxypropyl cellulose type (HPC-SSL SFP, HPC-SSL), concentration (2 %, 3.5 %, 5 %) and filler (lactose, calcium hydrogen phosphate (DCP)/microcrystalline cellulose (MCC)) on twin-screw wet granulation and subsequent tableting was studied. The aim was to identify the formulation of the highest tabletability which still fulfills the requirements of the disintegration. Lactose combined with 5 % binder enabled a higher tabletability and a faster disintegration than DCP/MCC. It was found that tabletability of lactose formulations can be increased by higher binder concentration and higher compression pressure while tabletability of DCP/MCC formulations can be only increased by higher compression pressure. It was observed that batches containing DCP/MCC failed the disintegration test, if the highest binder concentration and the highest compression pressure were used. To ensure a fast disintegration, the compression pressure or at least the binder concentration had to be low. Changing the disintegrant and its localization improved the DCP/MCC formulation, resulting in faster disintegration than lactose tablets. However, it also resulted in a lower tabletability. In this study best tablets were achieved with 3.5 % or 5 % binder and lactose as filler. These tablets presented the highest tabletability but still disintegrated in less than 500 s.


Subject(s)
Cellulose , Drug Compounding , Excipients , Lactose , Tablets , Cellulose/chemistry , Cellulose/analogs & derivatives , Lactose/chemistry , Excipients/chemistry , Drug Compounding/methods , Calcium Phosphates/chemistry , Chemistry, Pharmaceutical/methods , Pressure , Solubility
15.
Int J Pharm ; 656: 124116, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38615803

ABSTRACT

Inhalation of pharmaceutical aerosol formulations is widely used to treat respiratory diseases. Spatially resolved thermal characterization offers promise for better understanding drug release rates from particles; however, this has been an analytical challenge due to the small particle size (from a few micrometers down to nanometers) and the complex composition of the formulations. Here, we employ nano-thermal analysis (nanoTA) to probe the nanothermal domain of a pharmaceutical aerosol formulation containing a mixture of fluticasone propionate (FP), salmeterol xinafoate (SX), and excipient lactose, which is widely used to treat asthma and chronic obstructive pulmonary disease (COPD). Furthermore, atomic force microscopy-infrared spectroscopy (AFM-IR) and AFM force measurements are performed to provide nanochemical and nanomechanical information to complement the nanothermal data. The colocalized thermal and chemical mapping clearly reveals the surface heterogeneity of the drugs in the aerosol particles and demonstrates the contribution of the surface chemical composition to the variation in the thermal properties of the particles. We present a powerful analytical approach for in-depth characterization of thermal/chemical/morphological properties of dry powder inhaler particles at micro- and nanometer scales. This approach can be used to facilitate the comparison between generics and reference inhalation products and further the development of high-performance pharmaceutical formulations.


Subject(s)
Aerosols , Dry Powder Inhalers , Fluticasone , Lactose , Microscopy, Atomic Force , Particle Size , Powders , Salmeterol Xinafoate , Fluticasone/chemistry , Fluticasone/administration & dosage , Salmeterol Xinafoate/chemistry , Salmeterol Xinafoate/administration & dosage , Lactose/chemistry , Microscopy, Atomic Force/methods , Excipients/chemistry , Administration, Inhalation , Bronchodilator Agents/administration & dosage , Bronchodilator Agents/chemistry , Spectrophotometry, Infrared/methods , Chemistry, Pharmaceutical/methods , Surface Properties
16.
Int J Pharm ; 658: 124150, 2024 Jun 10.
Article in English | MEDLINE | ID: mdl-38663645

ABSTRACT

This study investigates decompression and ejection conditions on tablet characteristics by comparing compact densities and tensile strengths made using regular rigid dies and custom-built die systems that enable triaxial decompression. Die-wall pressure evolution during decompression and ejection stresses did not meaningfully impact the density and tensile strength of the materials tested: microcrystalline cellulose, crystalline lactose monohydrate, and mannitol. Furthermore, the apparent differences in tensile strength between rectangular cuboids and cylindrical compacts are unrelated to decompression and ejection conditions, but rather a consequence of their shapes and of the test configurations. This suggests that elastic and plastic deformations that may occur during decompression and ejection are not significantly influenced by die-wall pressure evolution. We thus conclude that while triaxial decompression and constraint-free ejection may allow the production of defect-free compacts for materials that otherwise are defect prone using a rigid die, they seem to pose no benefits when the materials already produce defect-free compacts using a rigid die.


Subject(s)
Cellulose , Excipients , Lactose , Mannitol , Tablets , Tensile Strength , Cellulose/chemistry , Lactose/chemistry , Mannitol/chemistry , Excipients/chemistry , Technology, Pharmaceutical/methods , Pressure , Drug Compounding/methods , Chemistry, Pharmaceutical/methods
17.
Bioprocess Biosyst Eng ; 47(6): 919-929, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38644439

ABSTRACT

The growing need in the current market for innovative solutions to obtain lactose-free (L-F) milk is caused by the annual increase in the prevalence of lactose intolerance inside as well as the newborn, children, and adults. Various configurations of enzymes can yield two distinct L-F products: sweet (ß-galactosidase) and unsweet (ß-galactosidase and glucose oxidase) L-F milk. In addition, the reduction of sweetness through glucose decomposition should be performed in a one-pot mode with catalase to eliminate product inhibition caused by H2O2. Both L-F products enjoy popularity among a rapidly expanding group of consumers. Although enzyme immobilization techniques are well known in industrial processes, new carriers and economic strategies are still being searched. Polymeric carriers, due to the variety of functional groups and non-toxicity, are attractive propositions for individual and co-immobilization of food enzymes. In the presented work, two strategies (with free and immobilized enzymes; ß-galactosidase NOLA, glucose oxidase from Aspergillus niger, and catalase from Serratia sp.) for obtaining sweet and unsweet L-F milk under low-temperature conditions were proposed. For free enzymes, achieving the critical assumption, lactose hydrolysis and glucose decomposition occurred after 1 and 4.3 h, respectively. The tested catalytic membranes were created on regenerated cellulose and polyamide. In both cases, the time required for lactose and glucose bioconversion was extended compared to free enzymes. However, these preparations could be reused for up to five (ß-galactosidase) and ten cycles (glucose oxidase with catalase).


Subject(s)
Enzymes, Immobilized , Glucose Oxidase , Lactose , Milk , beta-Galactosidase , beta-Galactosidase/metabolism , beta-Galactosidase/chemistry , Milk/chemistry , Lactose/metabolism , Lactose/chemistry , Glucose Oxidase/chemistry , Glucose Oxidase/metabolism , Enzymes, Immobilized/chemistry , Enzymes, Immobilized/metabolism , Animals , Aspergillus niger/enzymology , Glucose/metabolism , Glucose/chemistry , Catalase/metabolism , Catalase/chemistry , Membranes, Artificial
18.
Int J Pharm ; 657: 124122, 2024 May 25.
Article in English | MEDLINE | ID: mdl-38621619

ABSTRACT

The aim of this study was to investigate how the propensity for aerosolisation in binary adhesive mixtures was affected by the drug load, and to determine whether these findings could be linked to different blend states. Binary blends of two different lactose carriers, each with varying size and morphology, were prepared together with budesonide. In vitro aerosolisation studies were conducted at four different pressure drops, ranging from 0.5 to 4 kPa, utilising a Next Generation Impactor. Several dispersion parameters were derived from the relationship between the quantity of dispersed API and the pressure drop. The evolution of the parameters with drug load was complex, especially at low drug loads. While similar responses were observed for both carriers, the range of drug load that could be used varied significantly. The choice of carrier not only influenced the capacity for drug loading but also affected the spatial distribution of the API within the mixture, which, in turn, affected its aerosolisation propensity. Thus, the drug dispersion process could be linked to different configurations of the lactose carrier and budesonide in the blends, i.e. blend states. In conclusion, the study suggests that the concept of blend states can provide an explanation for the complex dispersion process observed in adhesive blends.


Subject(s)
Adhesives , Aerosols , Budesonide , Drug Carriers , Lactose , Budesonide/chemistry , Budesonide/administration & dosage , Lactose/chemistry , Administration, Inhalation , Adhesives/chemistry , Drug Carriers/chemistry , Particle Size , Chemistry, Pharmaceutical/methods
19.
J Sci Food Agric ; 104(11): 6769-6777, 2024 Aug 30.
Article in English | MEDLINE | ID: mdl-38563403

ABSTRACT

BACKGROUND: The general assumption that prebiotics reach the colon without any alterations has been challenged. Some in vitro and in vivo studies have demonstrated that 'non-digestible' oligosaccharides are digested to different degrees depending on their structural composition. In the present study, we compared different methods aiming to assess the digestibility of oligosaccharides synthesized by ß-galactosidase (ß-gal) of Lactobacillus delbruecki subsp. bulgaricus CRL450 (CRL450-ß-gal) from lactose, lactulose and lactitol. RESULTS: In the simulated gastrointestinal fluid method, no changes were observed. However, the oligosaccharides synthesized by CRL450-ß-gal were partially hydrolyzed in vitro, depending on their structure and composition, with rat small intestinal extract (RSIE) and small intestinal brush-border membrane vesicles (BBMV) from pig. Digestion of some oligosaccharides increased when mixtures were fed to C57BL/6 mice used as in vivo model; however, lactulose-oligosaccharides were the most resistant to the physiological conditions of mice. In general ß (1→6) linked products showed higher resistance compared to ß (1→3) oligosaccharides. CONCLUSION: In vitro digestion methods, without disaccharidases, may underestimate the importance of carbohydrates hydrolysis in the small intestine. Although BVMM and RSIE digestion assays are appropriate in vitro methods for these studies, in vivo studies remain the most reliable for understanding what actually happens in the digestion of oligosaccharides. © 2024 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.


Subject(s)
Digestion , Mice, Inbred C57BL , Oligosaccharides , Prebiotics , beta-Galactosidase , Prebiotics/analysis , Animals , beta-Galactosidase/metabolism , beta-Galactosidase/chemistry , Oligosaccharides/metabolism , Oligosaccharides/chemistry , Mice , Rats , Swine , Male , Lactulose/metabolism , Lactulose/chemistry , Bacterial Proteins/metabolism , Bacterial Proteins/chemistry , Intestine, Small/metabolism , Intestine, Small/enzymology , Lactobacillus/metabolism , Lactobacillus/enzymology , Hydrolysis , Lactose/metabolism , Lactose/chemistry
20.
Biomater Adv ; 160: 213849, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38599041

ABSTRACT

Spheroids derived from human mesenchymal stem cells (hMSCs) are of limited use for cartilage regeneration, as the viability of the cells progressively decreases during the period required for chondrogenic differentiation (21 days). In this work, spheroids based on hMSCs and a lactose-modified chitosan (CTL) were formed by seeding cells onto an air-dried coating of CTL. The polymer coating can inhibit cell adhesion and it is simultaneously incorporated into spheroid structure. CTL-spheroids were characterized from a morphological and biological perspective, and their properties were compared with those of spheroids obtained by seeding the cells onto a non-adherent surface (agar gel). Compared to the latter, smaller and more viable spheroids form in the presence of CTL as early as 4 days of culture. At this time point, analysis of stem cells differentiation in spheroids showed a remarkable increase in collagen type-2 (COL2A1) gene expression (~700-fold compared to day 0), whereas only a 2-fold increase was observed in the control spheroids at day 21. These results were confirmed by histological and transmission electron microscopy (TEM) analyses, which showed that in CTL-spheroids an early deposition of collagen with a banding structure already occurred at day 7. Overall, these results support the use of CTL-spheroids as a novel system for cartilage regeneration, characterized by increased cell viability and differentiation capacity within a short time-frame. This will pave the way for approaches aimed at increasing the success rate of procedures and reducing the time required for tissue regeneration.


Subject(s)
Cell Differentiation , Chitosan , Chondrogenesis , Lactose , Mesenchymal Stem Cells , Spheroids, Cellular , Chitosan/pharmacology , Chitosan/chemistry , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/cytology , Humans , Cell Differentiation/drug effects , Chondrogenesis/drug effects , Spheroids, Cellular/drug effects , Spheroids, Cellular/cytology , Lactose/pharmacology , Lactose/chemistry , Cell Survival/drug effects , Cells, Cultured , Collagen Type II/metabolism , Collagen Type II/genetics
SELECTION OF CITATIONS
SEARCH DETAIL